Mersana Therapeutics
(NASDAQ) MRSN
Mersana Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$33.18M
Net Income (TTM)
$70.08M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
MRSN News
MRSN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Mersana Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
102
CEO
Martin H. Huber, MD
Website
www.mersana.comHeadquarters
Cambridge, MA 02139, US
MRSN Financials
Key Financial Metrics (TTM)
Gross Margin
99%
Operating Margin
-2%
Net Income Margin
-2%
Return on Equity
2%
Return on Capital
-3%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$40.50M
Operating Income
$73.34M
EBITDA
$63.27M
Operating Cash Flow
$82.34M
Capital Expenditure
$132.00K
Free Cash Flow
$82.47M
Cash & ST Invst.
$134.62M
Total Debt
$28.60M
Mersana Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$11.01M
-12.6%
Gross Profit
$11.01M
-12.6%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
102
N/A
Net Income
$7.54M
+34.4%
EBITDA
$7.07M
+27.1%
Quarterly Fundamentals
Net Cash
$54.10M
-56.3%
Accounts Receivable
$168.00K
-83.2%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$2.29M
-84.9%
Return on Assets
-1.12%
N/A
Return on Invested Capital
-3.47%
N/A
Free Cash Flow
$3.19M
+62.8%
Operating Cash Flow
$3.19M
+62.8%